QS Investors’s Calumet Specialty Products CLMT Stock Holding History

QS Investors’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-876	Closed	-$7K	–	1970
2017 Q4	$7K	Buy	+876	New	+$7.3K	﹤0.01%	1579

Other funds holding CLMT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

WWM

Windsor Wealth Management Indianapolis, Indiana $546M AUM 16.47% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

QS Investors's CLMT Position: Q1 2018 in Review

QS Investors sold out of Calumet Specialty Products (CLMT) in Q1 2018, closing a stake of 876 shares — an estimated $7K sold.

QS Investors first reported a position in CLMT in Q4 2017 and held it in 1 quarter. The position peaked at $7K in Q4 2017. 72 funds tracked by Wall St. Rank hold CLMT as of Q1 2018.

QS Investors reported no remaining Calumet Specialty Products position as of Q1 2018 after selling out during the quarter.
QS Investors sold 876 Calumet Specialty Products shares in Q1 2018, an estimated $7K.
QS Investors first reported a position in Calumet Specialty Products in Q4 2017 and held it in 1 quarter.
QS Investors's Calumet Specialty Products position peaked at $7K in Q4 2017.
72 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2018.

Based on QS Investors's 13F filing for Q1 2018, filed 15 May 2018.